{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T02:08:59Z","timestamp":1787969339865,"version":"build-2784847793"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T00:00:00Z","timestamp":1678233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Aspirin is widely used in the primary and secondary prevention of cardiovascular and cerebrovascular diseases. Low-dose aspirin is also widely used to prevent pre-eclampsia and fetal growth retardation in utero. However, the use of aspirin during pregnancy is controversial. Since 1985, when aspirin was reported to be effective in obstetrics, numerous studies have attempted to determine the effect of low-dose aspirin on the morbidity of pre-eclampsia but have remained inconclusive. Guidelines for aspirin in preventing pre-eclampsia are different in different countries and regions. This article summarizes the research progress, mechanism, and application prospect of aspirin in preventing pre-eclampsia, providing a theoretical basis for the rational use of aspirin in pregnancy.<\/jats:p>","DOI":"10.3389\/fmed.2023.1111371","type":"journal-article","created":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T05:21:46Z","timestamp":1678252906000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Application of low dose aspirin in pre-eclampsia"],"prefix":"10.3389","volume":"10","author":[{"given":"Yu","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangdong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaojun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.semnephrol.2017.05.011","article-title":"Preeclampsia: pathogenesis, prevention, and long-term complications","volume":"37","author":"Jim","year":"2017","journal-title":"Semin Nephrol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"3263","DOI":"10.3390\/ijms20133263","article-title":"Preeclampsia: the relationship between uterine artery blood flow and trophoblast function","volume":"20","author":"Ridder","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis","volume":"216","author":"Roberge","year":"2017","journal-title":"Am J Obstet Gynecol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.revmed.2017.10.419","article-title":"Aspirin: indications and use during pregnancy","volume":"38","author":"Belhomme","year":"2017","journal-title":"Rev Med Interne."},{"key":"B5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0140-6736(78)91367-3","article-title":"Aspirin for the treatment of recurrent toxaemia","volume":"2","author":"Goodlin","year":"1978","journal-title":"Lancet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/S0140-6736(79)91996-2","article-title":"Effect of aspirin on incidence of pre-eclampsia","volume":"1","author":"Crandon","year":"1979","journal-title":"Lancet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/S0140-6736(85)92207-X","article-title":"Prevention of pre-eclampsia by early antiplatelet therapy","volume":"1","author":"Beaufils","year":"1985","journal-title":"Lancet."},{"key":"B8","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1136\/bmj.322.7282.329","article-title":"Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review","volume":"322","author":"Duley","year":"2001","journal-title":"BMJ."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data","volume":"369","author":"Askie","year":"2007","journal-title":"Lancet."},{"key":"B10","doi-asserted-by":"publisher","first-page":"819","DOI":"10.7326\/M14-1884","article-title":"Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement","volume":"161","author":"LeFevre","year":"2014","journal-title":"Ann Intern Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1055\/s-0035-1570381","article-title":"Prevention of preeclampsia with aspirin in multiple gestations: a systematic review and meta-analysis","volume":"33","author":"Bergeron","year":"2016","journal-title":"Am J Perinatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1056\/NEJMc1713798","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Nicolaides","year":"2017","journal-title":"N Engl J Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","article-title":"Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice","volume":"72","author":"Brown","year":"2018","journal-title":"Hypertension."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/AOG.0000000000003019","article-title":"202 Summary: Gestational Hypertension and Preeclampsia","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ijgo.12802","article-title":"The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention","volume":"145","author":"Poon","year":"2019","journal-title":"Int J Gynaecol Obstet."},{"key":"B16","volume-title":"Hypertension in Pregnancy: Diagnosis and Management","year":"2019"},{"key":"B17","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1515\/jpm-2021-0636","article-title":"International Academy of Perinatal Medicine (IAPM) guidelines for screening, prediction, prevention and management of pre-eclampsia to reduce maternal mortality in developing countries","volume":"51","author":"Stefanovic","year":"2023","journal-title":"J Perinat Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.preghy.2021.09.008","article-title":"The 2021 international society for the study of hypertension in pregnancy classification, diagnosis & management recommendations for international practice","volume":"27","author":"Magee","year":"2022","journal-title":"Pregnancy Hypertens."},{"key":"B19","volume-title":"WHO Recommendations on Antiplatelet Agents for the Prevention of Pre-eclampsia","year":"2021"},{"key":"B20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.earlhumdev.2016.09.007","article-title":"Preeclampsia; short and long-term consequences for mother and neonate","volume":"102","author":"Bokslag","year":"2016","journal-title":"Early Hum Dev."},{"key":"B21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.amjms.2017.03.012","article-title":"Potential value of coagulation parameters for suggesting preeclampsia during the third trimester of pregnancy","volume":"354","author":"Chen","year":"2017","journal-title":"Am J Med Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N Engl J Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3109\/14767058.2014.927860","article-title":"The impact of platelet functions and inflammatory status on the severity of preeclampsia","volume":"28","author":"Sahin","year":"2015","journal-title":"J Matern Fetal Neonatal Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"194","DOI":"10.2174\/1573396316666191224092405","article-title":"Preeclampsia emerging as a novel risk factor for cardiovascular disease in the offspring","volume":"16","author":"Karatza","year":"2020","journal-title":"Curr Pediatr Rev."},{"key":"B25","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1172\/JCI110814","article-title":"Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man","volume":"71","author":"FitzGerald","year":"1983","journal-title":"J Clin Invest."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/S0140-6736(89)91815-1","article-title":"Low-dose aspirin and twin pregnancy","volume":"2","author":"Trudinger","year":"1989","journal-title":"Lancet."},{"key":"B27","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1056\/NEJM198908103210603","article-title":"The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies","volume":"321","author":"Schiff","year":"1989","journal-title":"N Engl J Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.thromres.2011.01.005","article-title":"Thromboxane metabolite excretion during pregnancy\u2013influence of preeclampsia and aspirin treatment","volume":"127","author":"Perneby","year":"2011","journal-title":"Thromb Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.placenta.2015.01.004","article-title":"Aspirin inhibits expression of sFLT1 from human cytotrophoblasts induced by hypoxia, via cyclo-oxygenase 1","volume":"36","author":"Li","year":"2015","journal-title":"Placenta."},{"key":"B30","doi-asserted-by":"publisher","first-page":"18928","DOI":"10.1002\/jcp.28533","article-title":"Low-dose aspirin reduces hypoxia-induced sFlt1 release via the JNK\/AP-1 pathway in human trophoblast and endothelial cells","volume":"234","author":"Lin","year":"2019","journal-title":"J Cell Physiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jri.2017.10.044","article-title":"The effect of acetyl salicylic acid (Aspirin) on trophoblast-endothelial interaction in vitro","volume":"124","author":"Xu","year":"2017","journal-title":"J Reprod Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1016\/j.ajpath.2016.08.010","article-title":"Low-dose acetylsalicylic acid treatment modulates the production of cytokines and improves trophoblast function in an in vitro model of early-onset preeclampsia","volume":"186","author":"Panagodage","year":"2016","journal-title":"Am J Pathol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1139\/cjpp-2018-0087","article-title":"Ameliorative effects of aspirin against lipopolysaccharide-induced preeclampsia-like symptoms in rats by inhibiting the pro-inflammatory pathway","volume":"96","author":"Sun","year":"2018","journal-title":"Can J Physiol Pharmacol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.freeradbiomed.2017.01.010","article-title":"Aspirin prevents TNF-\u03b1-induced endothelial cell dysfunction by regulating the NF-\u03baB-dependent miR-155\/eNOS pathway: role of a miR-155\/eNOS axis in preeclampsia","volume":"104","author":"Kim","year":"2017","journal-title":"Free Radic Biol Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1007\/s00109-018-1695-9","article-title":"Low-dose aspirin treatment enhances the adhesion of preeclamptic decidual mesenchymal stem\/stromal cells and reduces their production of pro-inflammatory cytokines","volume":"96","author":"Khanabdali","year":"2018","journal-title":"J Mol Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ajog.2016.10.016","article-title":"Antiplatelet therapy before or after 16 weeks' gestation for preventing preeclampsia: an individual participant data meta-analysis","volume":"216","author":"Meher","year":"2017","journal-title":"Am J Obstet Gynecol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ajog.2018.03.018","article-title":"Optimal aspirin dosing for preeclampsia prevention","volume":"219","author":"Seidler","year":"2018","journal-title":"Am J Obstet Gynecol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.ajog.2017.12.238","article-title":"Meta-analysis on the effect of aspirin use for prevention of preeclampsia on placental abruption and antepartum hemorrhage","volume":"218","author":"Roberge","year":"2018","journal-title":"Am J Obstet Gynecol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ijcard.2016.06.104","article-title":"A brief review on the mechanisms of aspirin resistance","volume":"220","author":"Du","year":"2016","journal-title":"Int J Cardiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1111\/1471-0528.13914","article-title":"Low dose aspirin and pregnancy: how important is aspirin resistance?","volume":"123","author":"Navaratnam","year":"2016","journal-title":"BJOG."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.jacc.2013.06.024","article-title":"Toward a genomic definition of aspirin resistance","volume":"62","author":"Bishopric","year":"2013","journal-title":"J Am Coll Cardiol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1399-0004.2008.01105.x","article-title":"The genetics of antiplatelet drug resistance","volume":"75","author":"Feher","year":"2009","journal-title":"Clin Genet."},{"key":"B43","first-page":"334","article-title":"Aspirin resistance may be associated with adverse pregnancy outcomes","volume":"32","author":"W\u00f3jtowicz","year":"2011","journal-title":"Neuro Endocrinol Lett."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1111371\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T05:21:49Z","timestamp":1678252909000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1111371\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,8]]},"references-count":43,"alternative-id":["10.3389\/fmed.2023.1111371"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1111371","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,8]]},"article-number":"1111371"}}